Perindopril Amlodipine for the Treatment of Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 837 participants.
Also called NCT01556997
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 837 participants
- Sponsor
- Symplmed Pharmaceuticals LLC
- Registry
-
NCT01556997
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01556997. Randomized; double masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2015-08-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perindopril Amlodipine for the Treatment of Hypertension
- Acronym
- PATH
- Condition
- Essential Hypertension
- Intervention (Drug)
- XOMA 985
- Intervention (Drug)
- Amlodipine Besylate
- Intervention (Drug)
- Perindopril Erbumine
- Lead sponsor
- Symplmed Pharmaceuticals LLC
Record details
- Record id
cardio:ct-nct01556997- Content hash
789292ef1db22dc23a23e507cb658f3348f3914804e1273295375c6e390b7c81